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Introduction
Helicobacter pylori is a microaerophilic gram negative 
spiral bacterium that is able to localize in the stomach 
mucosa for at least tens of thousands of year. Several 
epidemiological studies have shown that the H. pylori 
infection causes a variety of gastrointestinal symptoms 
such as chronic gastritis and adenocarcinoma (Suerbaum 
and Michetti, 2002). Although the incidence and mortality 
of gastric cancer (GC) have declined in recent decades, it 
is the third-ranking cause of cancer which leads to death 
and the fifth most common malignant disease in the world 
(Ferlay et al., 2015). Histologically, GC divided into the 
intestinal- and the diffuse-type carcinomas. Previous 
studies have suggested that the interaction between host 
and environmental factors are jointly responsible for 
development of GC (Leung et al., 2006). 
Stomach cancer is very common in Iran (Alireza et 
al., 2005a; Alireza et al., 2005b). Ardabil, a volcanic and 
mountainous land in Northwestern province of Iran that 
is located in Caspian Sea littoral, includes the highest rate 
of GC within the country (ASR of 51.8/100,000 in men 
and 24.9/100,000 in women) (Sadjadi et al., 2003; Babaei 
et al., 2010). In this area, more than one-third of the GC 
occurs in the cardia site of the stomach which constitutes 
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 Background: Ardabil, a Northwestern province of Iran, was found to have the highest rate of gastric cancer 
(GC) in the country (ASRs = 51.8/100,000 for males and 24.9/100,000 for females) and one of the highest gastric 
cardia cancer rates in the world. The aim of the present study was to assess the associations of the cagA and 
babA2 status of Helicobacter pylori with GC in the Ardabil population. Materials and Methods: A total of 
103 patients with non-atrophic gastritis (56) and GC (47), who underwent endoscopy at the Imam Khomeini 
Hospital in Ardabil, were assessed. The status of 16S rDNA, cagA and babA2 genes was determined using PCR 
and histopathological assessment was performed. Results: The following genotypic frequency was observed: 
cagA+ (50.6%), cagA– (49.4%), babA2+ (26.5%), babA2– (73.5%) cagA+/babA2+ (19.3%), cagA–/babA2+ (7.2%), 
cagA+/babA2– (31.3%), cagA–/babA2– (42.2%). Although the frequency of the cagA+, cagA+/babA2+ and cagA–/
babA2+ genotypes in patients with GC (55.6%, 25.9%, and 14.8%, respectively) was higher than in those with 
NAG (48.2%, 16.1%, and 3.6%, respectively), the difference did not reach significance. In contrast, the presence 
of the babA2 gene (40.7% vs 19.6%) significantly increased the risk of GC; the age-sex-adjusted odds ratio (95% 
confidence interval) was 5.068 (1.506-17.058; P=0.009), by multiple logistic regression. Conclusions: It is proposed 
that the H. pylori babA2 positivity might be considered as an important determinant of GC risk in Ardabil. 
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only 5-10% of the entire stomach, and the incidence for 
cardia sub site was 26.4 and 8.6 for males and females, 
respectively (Derakhshan et al., 2004; Babaei et al., 2009). 
H. pylori infection has been measured as 89% and 69% 
in Ardabil province and Iran, respectively (Sadjadi et al., 
2003; Malekzadeh et al., 2004; Nouraie et al., 2009). We 
have previously indicated that all the Iranian H. pylori 
strains, including those with Ardabil signature, represent 
the European ancestry, influenced by extensive genetic 
exchange with neighboring countries. However, they 
have well preserved ethnic and geographic signatures 
within the country (Latifi-Navid et al., 2010). Ardabil 
isolates showed approximately equal contribution from 
the two European ancestral sources, Ancestral Europe1 
and Ancestral Europe2 (AE1 and AE2) that were found in 
purer form in Central Asia (AE1) and North East Africa 
(AE2).
CagA is one of the putative virulence factors of H. 
pylori, which is encoded by the cytotoxin-associated 
gene A (cagA) that is located in the cag pathogenicity 
island (cag PAI) and directly translocated into host gastric 
epithelial cells by a type-IV secretion system (T4SS) after 
bacterial attachment (Mattar et al., 2007; Ohnishi et al., 
2008). It promotes the tumorigenesis of GC by interfering 
with multiple signaling pathways (Yong et al., 2015). 
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Approximately, the 50 to 60% of H. pylori strains harbor 
cagA (Abasiyanik et al., 2002; Basso et al., 2008), whose 
expression induces the production of IL-8 and mucosal 
inflammation in cultured gastric cells (Chang et al., 2015; 
Ferreira et al., 2015). Several studies have been reported 
that the individuals harboring cagA-positive strains 
suffer from a high risk for gastric mucosal atrophy and 
GC, compared to those with strains that lack the cag PAI 
(Sozzi et al., 2005; Tan et al., 2006). orf17 and particularly 
cagL, which are other genotypes of cag PAI, significantly 
increased the risk of peptic ulceration (PU), but not GC. 
No significant association was found between the cagH 
and cagG genotypes and the risk of both the PU and the 
GC (Raei et al., 2015). H. pylori strains may be classified 
into two types: type I and type II, based on possessing the 
cag PAI (Bagheri et al., 2013). The East Asian subtype of 
the cagA gene (A, B, D) strongly linked to severe gastritis 
and GC, in comparison with western subtype (A, B,C) 
(Argent et al., 2008). 
Another important virulence factor is babA2 (blood 
group antigen binding adhesion) that encoded by the 
babA2 gene. BabA is a 78-KDa outer membrane protein 
(OMP) that binds to lewis b antigens and ABO antigen 
on the surfaces of gastric epithelial cells (Gerhard et al., 
1999). Two babA allelic types identified (babA1 and 
babA2); however, only the babA2 gene is functionally 
active. The presence of the 10-bp insertion is the cause 
of the difference between babA1 and babA2 (Ilver et 
al., 1998). Expression of the babA2 gene has also been 
associated with the risk of GC (Lee et al., 2006). 
Since the diagnosis of GC in the earlier stages of 
infection is difficult; therefore, eradication of the H. pylori 
infection might be the main way of cancer conservation. 
Therefore, it is necessary to determine which strains of 
H. pylori lead to GC. H. pylori-specific genotypes could 
determine the clinical consequences and contribute to 
understanding of the cause of high tendency for GC 
(Figueiredo et al., 2002; Peek et al., 2010). The aim of 
the present study was therefore to determine the H. pylori 
cagA and babA2 status and their associations with GC in 
Ardabil population.
Materials and Methods
Participants of the study
From February 2012 to January 2014, a total number of 
103 consecutive adult patients who underwent endoscopy 
at the Imam Khomeini Hospital in Ardabil, Northwestern 
Iran, participated in this study. All patients were born and 
grew up in the rural or urban areas of Ardabil province. 
Fresh gastric mucosal biopsy specimens were obtained 
from each patient and classified by endoscopic and 
histopathological examinations. The study population 
consisted of patients with none-atrophic gastritis (NAG) 
and GC. None of the patients had received none steroidal 
anti-inflammatory drugs or antibiotics within the previous 
three months, and all the participants signed a written 
informed consent. 
Histopathological assessment
The biopsy samples were fixed in 10% formalin and 
embedded in paraffin, and were stained by hematoxylin–
eosin, Alcian blue-periodic acid Shiff (pH 2.5) and Giemsa 
for light microscopy, and histopathological evaluations 
were also applied according to the updated Sydney 
classification system (Dixon et al., 1996). 
Diagnosis of H. pylori infection
During endoscopy, of each patient four biopsies (two 
from the antrum and two from the corpus) were taken 
for histological examination and DNA extraction. The 
Biopsy specimens were frozen at -80ºC until processing. 
Detection of H. pylori was performed by using a specific 
primer set (HP1/HP2) of H. pylori 16S rDNA, selected 
from some previous published works that produced the 
PCR fragments of 519-bp (Table 1).
DNA extraction and genotyping of H. pylori
DNA was extracted from the biopsy specimens by 
using Genomic DNA purification kit (DNGTM-Plus, 
CinnaGen Co., Iran) according to the manufacturer’s 
recommendations, and stored at -20ºC. After DNA 
extraction, polymerase chain reaction (PCR) was 
performed in a volume of 30 µL reaction volume 
containing 50 ng of genomic DNA, 3 µL of 10X PCR 
buffer (CinnaGen, Iran), 1 mM MgCl2, 200 µM of each 
dNTP (CinnaGen Co., Iran), 0.5 µM of each specific primer 
and 2 U of Taq DNA polymerase (CinnaGen Co., Iran). 
Amplification was also performed under the following 
conditions: for cagA: 35 cycles of 40 sec at 94°C, 1 min 
at 50°C (C-terminus), 55°C (middle region), or 56°C 
(N-terminus) and 1 min at 72°C, and for babA2: 35 cycles 
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Table 1. Oligonucleotide Primers Used for PCR
Genes  Primers Sequences (5'"3’) Size of PCR Optimized
    products annealing 
     (bp) temperature (ºC) 
16S rDNA HP1  GCAATCAGCGTCAGTAATGTTC 519 56 (Lu et al., 2002)
 HP2  GCTAAGAGATCAGCCTATGTCC   
cagA N-terminus CagA/N-F CCATTTTAAGCAACTCCATAAACC 413 56 (Bakhti et al., 2015)
  CagA/N-R CTGCAAAAGATTGTTTGGCagA   
 Middle region CagA/M-F GGCAATGGTGGTCCTGGAGCTAGGC 243 55 (Bakhti et al., 2015)
  CagA/M-R GGAAATCTTTAATCTCAGTTCGG   
 C-terminus CAG1 ACC CTAGTC GGT AAT GGG TTA 591-856 50 (Sicinschi et al., 2010)
  CAG2 GTA ATT GTC TAG TTT CGC   
babA2  BabA2F AATCCAAAAAGGAGAAAAAGTATGAAA 852 55 (Gerhard et al., 1999)
  BabA2R TGTTAGTGATTTCGGTGTAGGACA   
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of 40 sec at 94°C, 1 min at 55°C and 1 min at 72°C. PCR 
products were visualized by electrophoresis in 1% agarose 
gel and examined under UV illumination. Primers used 
for PCR assays of 16S rDNA, cagA and babA2 genes are 
also listed in Table 1. As controls, amplified fragments of 
each gene from seven isolates were purified and sequenced 
with both forward and reverse primers by using BigDye 
technology on an ABI3700XL DNA sequencer (Applied 
Biosystems). The BLAST program (http://www.ncbi.nlm.
nih.gov) was used to match the nucleotide sequences with 
the published sequences in GenBank.
Data analysis 
Chi-square (χ2) or Fisher’s exact tests were used to 
assess the associations between the cagA and babA2 
status and GC, whether independently or in combination. 
Patients with NAG were considered as controls. Odds 
ratios (ORs) and the corresponding 95% confidence 
intervals (CIs) were also calculated. The Forward Stepwise 
LR (Likelihood Ratio) multiple logistic regression analysis 
was used for each gene individually, with adjustment for 
the potential confounders, including a threshold age of 
40 years and sex. All the P-values were two-sided and 
P<0.05 was considered statistically significant. Data were 
collected and analyzed by using SPSS software (SPSS 
Science, Chicago, IL) version 19.0.
Results 
Patients characteristics 
The study population consisted of 103 patients, among 
theses, 56 (54.37%) were diagnosed as gastritis and 47 
(45.63%) had suffered from GC. Occurrence of H. pylori 
infection was 80.58% (83/103). Among them, the results 
of 16S rDNA PCR for 57.44% (27/47) of patients with 
GC and 100% (56/56) of those with NAG were positive. 
Generally, the total number of 83 H. pylori positive 
patients, 49 (59%) males and 34 (41%) females, with an 
average age of 48.7 years (the age range varied between 
20 and 90 years), were enrolled in the final analysis. In GC 
group, 70.4% (19/27) and 29.6% (8/27) were males and 
females, respectively. Characteristics of patients according 
to age and sex were shown in Table 2. Results of statistical 
analysis showed a significant association between age (OR 
= 11.027, 95% CI, 1.376-88.370; P=0.008), but not sex 
(OR = 2.058, 95% CI, 0.773-5.878; P=0.162), and GC. 
In this study, the prevalence of GC patients according 
to the anatomical site of the tumor origin was as follows: 
53.19% (25/47) with gastric cardia cancer (GCC), 44.68% 
(21/47) with non-cardia GC (NCGC) and 2.13% (1/47) 
with both the GCC and the NCGC. Of the 47 GC patients, 
27 were infected with H. pylori; of them 12 (44.44%) 
were with GCC, 14 (51.85%) with NCGC and 1 (3.70%) 
with both the GCC and the NCGC. The prevalence of the 
intestinal- and the diffuse-type of adenocarcinoma and the 
squamous-cell carcinoma and the mucinous carcinoma of 
the stomach was 65.22% (30/46), 30.43% (14/46), 2.17% 
(1/46) and 2.17% (1/46), respectively. This information 
was not available for one patients. Among of H. pylori 
infected patients, 53.85% (14/26) and 46.15% (12/26) had 
the intestinal- and the diffuse-type of adenocarcinoma, 
respectively. None of the patients had a mixed type of 
adenocarcinoma.  
Genotyping of cagA and babA2 
The distribution of the cagA or babA2 positive and 
negative strains in patients was shown in Table 3. The 
cagA and babA2 genes were detected in 50.6% (42/83) 
and 26.5% (22/83) of H. pylori strains. In this study, the 
total prevalence of the cagA–, babA2–, cagA+/babA2+, 
cagA–/babA2+, cagA+/babA2– and cagA–/babA2– 
were as follows: 49.4% (41/83), 73.5% (61/83), 19.3% 
(16/83), 7.2% (6/83), 31.3% (26/83) and 42.2% (35/83), 
respectively. The prevalence of the cagA+ and babA2– 
strains was higher than cagA– and babA2+ strains. In our 
study, strains carrying the cagA and babA2 genes were 
also more frequent in GC patients (55.6% and 40.7%, 
respectively) than in the control group (NAG) (48.2% and 
19.6%, respectively). However, no significant association 
was found between the cagA+ strains and the risk of GC 
(P>0.05). Although, the prevalence of the cagA+/babA2+ 
and cagA–/babA2+ genotype combinations in patients 
with GC (25.9% and 14.8%, respectively) was higher than 
in those with NAG (16.1% and 3.6%, respectively), no 
significant association with GC was found. Furthermore, 
the cagA+/babA2– and cagA–/babA2– genotype 
combinations did not show any significant association with 
GC (P>0.05). The presence of the babA2 gene significantly 
Table 2. Distribution of Study Patients According to 
Age and Sex 
  Age   Sex  
Disease < 40 >= 40  Total Females Males Total
 N (%) N (%)  N (%) N (%) 
NAG 17 (31.5) 37 (68.5) 54 26 (46.4) 30 (53.6) 56
GC 1 (4) 24 (96) 25 8 (29.6) 19 (70.4) 27
Total 18 (22.8) 61 (77.2) 79 34 (41) 49 (59) 83
Abbreviations: NAG, non-atrophic gastritis; GC, gastric cancer
Table 3. Association between the H. pylori cagA and babA2 Genes and GC Risk
Genotypes NAGN (%) GCN (%) TotalN (%) OR (95% CI) 2-tailed P-value
cagA+ 27 (48.2) 15 (55.6) 42 (50.6) 1.343 (0.435-3.773) 0.531
cagA– 29 (51.8) 12 (44.4) 41 (49.4)  
babA2+ 11 (19.6) 11 (40.7) 22 (26.5) 2.813 (1.022-7.737) 0.041
babA2– 45 (80.4) 16 (59.3) 61 (73.5)  
cagA+/babA2+ 9 (16.1) 7 (25.9) 16 (19.3) 1.828 (0.895-5.985) 0.286
cagA–/babA2+ 2 (3.6) 4 (14.8) 6 (7.2) 4.696 (0.803-27.461) 0.064
cagA+/babA2– 18 (32.1) 8 (29.6) 26 (31.3) 0.889 (0.328-2.412) 0.817
cagA–/babA2– 27 (48.2) 8 (29.6) 35 (42.2) 0.452 (0.170-1.203) 0.108
Abbreviations: NAG, non-atrophic gastritis; GC, gastric cancer; OR, odds ratio; CI, confidence interval
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increased the risk of GC in the multiple logistic regression 
with adjustment for age and sex (OR = 5.068, 95% CI, 
1.506-17.058; P=0.009).
Discussion
Ardabil, a Northwestern province of Iran, is one 
of the areas with the highest GC incidence rate in the 
world. In the present study, we therefore investigated 
the association of the cagA and babA2 status with the 
risk of GC in Ardabil population. Through analyzing the 
data by means of logistic regression, the results showed 
no significant association between the cagA status of 
H. pylori and GC risk; however, the importance of 
CagA EPIYA polymorphisms has not been confirmed 
in Ardabil population yet; therefore, determining the 
associations of the CagA EPIYA polymorphisms with 
GC is important in this high-risk area. Recent studies 
have shown that the multiple repeats of H. pylori CagA 
EPIYA-C phosphorylation sites predict risk of gastric 
ulcer (GU) in Iran (Honarmand-Jahromy et al., 2015). 
The GU and GC have etiologic factors in common, which 
are likely to be caused by the H. pylori-induced atrophic 
gastritis (Hansson et al., 1996). We found that the cagA 
gene is highly prevalent in Ardabil patients (50.6%), but 
it could not be considered as an important risk factor for 
GC. However, in agreement with other studies (Dabiri 
et al., 2009; Joober et al., 2012), a high frequency of the 
cagA gene was also observed in GC patients in our study 
(55.6%). Several studies on Tehran population, of Iran, 
indicated no significant association between the presence 
of the cagA gene and GC risk (Jafari et al., 2008; Dabrii 
et al., 2010; Bagheri et al., 2013). In contrast, study 
conducted by Cittelly et al. in Colombians showed that 
the frequency of the cagA gene was significantly higher 
in GC patients (80%) than in control groups (51.4%) 
(P<0.01). They proposed that the presence of the cagA 
gene significantly increased the risk of GC (Cittelly et 
al., 2002). Also, study performed by Cavalcant et al. from 
a high-risk area of GC in Brazil demonstrated that the 
presence of the cagA gene particularly associated with the 
risk of GC (OR=10.36) (Cavalcante et al., 2012). A recent 
follow-up study from a high-risk area of GC in Spain 
showed that infection with cagA+/vacA s1/m1 strains was 
related to the progression of gastric precancerous lesions 
(OR = 4.80) compared with those infected with strains 
that harbored the cagA–/vacAs2/m2 genotype (González 
et al., 2011). In other study which was performed in a 
low-risk area of Okinawa of Japan, a strong relationship 
was found between cagA gene and GC risk in comparison 
with control groups, in a multiple logistic regression 
(OR = 6.68) (Matsunari et al., 2012). The prevalence 
of the cagA gene in Western and Eastern countries was 
reported to be 60% and 95%, respectively, however, 
only in Western countries, a significant association with 
GC was found (Kim et al., 2001; González et al., 2011). 
A meta-analysis conducted by Zhao et al. also showed 
that the H. pylori CagA antibody of the serum could not 
be useful for detecting GC in East Asian countries, with 
the highest incidence rates of GC (Zhao et al., 2014). 
This is in agreement with the results of the present study 
which was conducted in a genotype level and restricted 
to Ardabil, with the highest GC incidence rate in Iran and 
different ethnic group characteristics, Azeri with an Altaic 
language family. Interestingly, it has also been shown 
that the H. pylori CagA-negative non-virulent isolates 
may be a potential risk factor of pancreatic cancer (Chen 
et al., 2015).
Our findings demonstrated that the prevalence of the 
subjects harboring babA2– strains was significantly higher 
than the subjects with babA2+ strains. The babA2+ H 
pylori isolates were present in approximately 26.5% of 
the study population. The patients infected with the H. 
pylori strains which carry babA2 gene showed a higher 
risk of developing GC which was about 5.068 fold, 
by the multiple logistic regression; therefore, it could 
be considered an important virulence factor in Ardabil 
population. We have previously shown no significant 
difference in the distribution of the babA2 and cagA genes 
among H. pylori isolates from high (34.2% and 75.6%, 
respectively) and low (44.4% and 63.9%, respectively) 
incidence GC areas (P>0.05) (Latifi-Navid et al., 2013). 
In Iran, the frequency of babA2 genotype was 40.6% 
(Abadi et al., 2013; Latifi-Navid et al., 2013), which 
was strongly associated with GC in comparison with 
the control groups (P=0.0004) (Abadi et al., 2013). 
Similarly, study conducted by Gerhard et al. showed that 
frequency of the babA2 gene in GC patients (78%) was 
higher than those with gastritis (51%), with significant 
difference (Gerhard et al., 1999). Erzin et al. showed that 
the frequency of the babA2 gene in GC patients (87.9%) 
was higher than those with NAG (23.3%) (P=0) (Erzin et 
al., 2006). Furthermore, in Germany, Turkey, or northern 
Portugal, babA2 expression was closely associated with 
the severity of gastrointestinal disease (Gerhard et al., 
1999; Azevedo et al., 2008; Erzin et al., 2008), while 
in Portuguese and Thai populations, the presence of the 
babA2 gene was not associated with GC risk (Gatti et al., 
2006; Chomvarin et al., 2008). These results reflect the 
fact that the associations of H. pylori virulence genes/
alleles with GC risk have been widely varied according 
to geographic variation/ or ethnic origin. 
We proposed that the H. pylori babA2 positivity 
might be considered as an important determinant of 
GC risk in Ardabil. Hence, this study provided us with 
valuable information which might be helpful to reduce the 
incidence of GC in high-risk areas, particularly Ardabil. 
We propose that more investigations with a sufficient 
number of samples are necessary in order to better 
depicting the bacterial genotype diversity and the role of 
environmental and host factors and their associations with 
GC in this the very high-incidence area. 
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